– The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield’s expertise in drug discovery to address high unmet needs among rare disease patients – SAN FRANCISCO, March 22, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.